rs146322225
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_024105.4(ALG12):āc.652A>Gā(p.Ile218Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000096 in 1,614,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024105.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALG12 | NM_024105.4 | c.652A>G | p.Ile218Val | missense_variant | 5/10 | ENST00000330817.11 | |
ALG12 | XM_017028936.2 | c.652A>G | p.Ile218Val | missense_variant | 5/10 | ||
ALG12 | XM_017028937.2 | c.652A>G | p.Ile218Val | missense_variant | 5/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALG12 | ENST00000330817.11 | c.652A>G | p.Ile218Val | missense_variant | 5/10 | 1 | NM_024105.4 | P1 | |
ALG12 | ENST00000492791.1 | c.184A>G | p.Ile62Val | missense_variant, NMD_transcript_variant | 1/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251102Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135800
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461746Hom.: 0 Cov.: 34 AF XY: 0.0000454 AC XY: 33AN XY: 727162
GnomAD4 genome AF: 0.000564 AC: 86AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.000537 AC XY: 40AN XY: 74526
ClinVar
Submissions by phenotype
ALG12-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 218 of the ALG12 protein (p.Ile218Val). This variant is present in population databases (rs146322225, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with ALG12-related conditions. ClinVar contains an entry for this variant (Variation ID: 578572). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
ALG12-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 28, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at